Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

MMAF (hydrochloride)

MMAF (Monomethylauristatin F) hydrochloride is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF hydrochloride is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A[1][2][3].

Product Specifications

CAS Number

1415246-68-2

Product Name Alternative

Monomethylauristatin F (hydrochloride)

UNSPSC

12352203

Target

ADC Payload; Microtubule/Tubulin

Type

ADC Related

Related Pathways

Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage; Cytoskeleton

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/MMAF-Hydrochloride.html

Purity

99.93

Solubility

DMSO : 50 mg/mL (ultrasonic) |H2O : ≥ 100 mg/mL

Smiles

CC(C)[C@H](NC)C(N[C@H](C(N([C@@H]([C@@H](C)CC)[C@H](OC)CC(N1CCC[C@@]1([H])[C@H](OC)[C@@H](C)C(N[C@H](C(O)=O)CC2=CC=CC=C2)=O)=O)C)=O)C(C)C)=O.Cl

Molecular Formula

C39H66ClN5O8

Molecular Weight

768.42

References & Citations

[1]Doronina SO, et al. Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity. Bioconjug Chem. 2006 Jan-Feb;17 (1) :114-24.|[2]Lee JW, et al. EphA2 targeted chemotherapy using an antibody drug conjugate in endometrial carcinoma. Clin Cancer Res. 2010 May 1;16 (9) :2562-70.|[3]Lee JJ, et al. Enzymatic prenylation and oxime ligation for the synthesis of stable and homogeneous protein-drug conjugates for targeted therapy. Angew Chem Int Ed Engl. 2015 Oct 5;54 (41) :12020-4.|[4]Kim EG, et al. Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted CancerTherapeutics.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

ADC Related

Clinical Information

No Development Reported

Isoform

Auristatin

Citation 01

Oncol Rep. 2021 Feb;45 (2) :776-785.|J Control Release. 2018 May 10;277:48-56.|Mol Cancer Ther. 2023 Apr 3;22 (4) :459-470.|Mol Ther Nucleic Acids. 2018 Mar 2;10:227-236.|Patent. US20210393733A1.|Research Square Preprint. 2023 Dec 4.|Research Square Print. 2023 Jan 6th.|Target Oncol. 2019 Oct;14 (5) :577-590.|University of Minnesota. 2022 Sep.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Methyl 2-amino-5-cyclohexylthiophene-3-carboxylate
AEC62354-01 50 mg

Methyl 2-amino-5-cyclohexylthiophene-3-carboxylate

Sign In for Pricing
View Details
Methyl 2-amino-5-cyclohexylthiophene-3-carboxylate
AEC62354-02 0.5 g

Methyl 2-amino-5-cyclohexylthiophene-3-carboxylate

Sign In for Pricing
View Details
Spautin-1 (6-fluoro-N-[4-fluorobenzyl]quinazolin-4-amine, Specific and Potent AUtophagy Inhibitor 1, C43, Autophagy Inhibitor II)
217803 10 mg

Spautin-1 (6-fluoro-N-[4-fluorobenzyl]quinazolin-4-amine, Specific and Potent AUtophagy Inhibitor 1, C43, Autophagy Inhibitor II)

Sign In for Pricing
View Details
GAL3ST2 Recombinant Protein (Human)
RP039376 100 µg

GAL3ST2 Recombinant Protein (Human)

Sign In for Pricing
View Details
Rabbit Polyclonal ZNF599 Antibody [Biotin]
NBP2-98118B 0.1 mL

Rabbit Polyclonal ZNF599 Antibody [Biotin]

Sign In for Pricing
View Details
Bar Magnets, Alnico
1070040/4 1 Each

Bar Magnets, Alnico

Sign In for Pricing
View Details